DEA’s Proposed Rule to Reschedule Marijuana Could Reduce Obstacles to Medical Research but Public Input Is Needed to Fill in Knowledge Gaps

In sum, rescheduling marijuana will ease research barriers, which could invite investment by pharmaceutical companies with robust research and development capabilities to discover new FDA-approved …